Abstract:Abstract Development of new drugs is of high interest for the field of cardiac and cardiovascular diseases, which are a dominant cause of death worldwide. Before being allowed to be used and distributed, every new potentially therapeutic compound must be strictly validated during preclinical and clinical trials. The preclinical studies usually involve the in vitro and in vivo evaluation. Due to the increasing reporting of discrepancy in drug effects in animal and humans and the requirement to reduce the number of animals used in research, improvement of in vitro models based on human cells is indispensable. Primary cardiac cells are difficult to access and maintain in cell culture for extensive experiments; therefore, the human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) became an excellent alternative. This technology enables a production of high number of patient- and disease-specific cardiomyocytes and other cardiac cell types for a large-scale research. The drug effects can be extensively evaluated in the context of electrophysiological responses with a use of well-established tools, such as multielectrode array (MEA), patch clamp, or calcium ion oscillation measurements. Cardiotoxicity, which is a common reason for withdrawing drugs from marketing or rejection at final stages of clinical trials, can be easily verified with a use of hiPSC-CM model providing a prediction of human-specific responses and higher safety of clinical trials involving patient cohort. Abovementioned studies can be performed using two-dimensional cell culture providing a high-throughput and relatively lower costs. On the other hand, more complex structures, such as engineered heart tissue, organoids, or spheroids, frequently applied as co-culture systems, represent more physiological conditions and higher maturation rate of hiPSC-derived cells. Furthermore, heart-on-a-chip technology has recently become an increasingly popular tool, as it implements controllable culture conditions, application of various stimulations and continuous parameters read-out. This paper is an overview of possible use of cardiomyocytes and other cardiac cell types derived from hiPSC as in vitro models of heart in drug research area prepared on the basis of latest scientific reports and providing thorough discussion regarding their advantages and limitations.

Engineering Cardiac Tissue for Advanced Heart‐on‐a‐chip Platforms

Architecture design and advanced manufacturing of heart-on-a-chip: scaffolds, stimulation and sensors

Micro‐Engineered Heart Tissues on‐Chip with Heterotypic Cell Composition Display Self‐Organization and Improved Cardiac Function

Fabrication and Biomedical Applications of Heart-on-a-chip

Heart-on-a-chip systems with tissue-specific functionalities for physiological, pathological, and pharmacological studies

Biomimetic Cardiac Microsystems for Pathophysiological Studies and Drug Screens

Recent developments in organ-on-a-chip technology for cardiovascular disease research

Design and fabrication of an integrated heart-on-a-chip platform for construction of cardiac tissue from human iPSC-derived cardiomyocytes and in situ evaluation of physiological function

Engineered human cardiac tissues for modeling heart diseases

Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases

Recent progress of organ-on-a-chip towards cardiovascular diseases: advanced design, fabrication, and applications

Engineering Three-Dimensional Cardiac Microtissues for Potential Drug Screening Applications.

Sensor-free and Sensor-based Heart-on-a-chip Platform: A Review of Design and Applications

Cardiac Organoids: A 3D Technology for Disease Modeling and Drug Screening.

Engineered platforms for mimicking cardiac development and drug screening

Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research

Engineered Circulatory Scaffolds for Building Cardiac Tissue

Continuous Contractile Force and Electrical Signal Recordings of 3D Cardiac Tissue Utilizing Conductive Hydrogel Pillars on a Chip

Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications

Engineering a living cardiac pump on a chip using high-precision fabrication

Engineering Human Cardiac Muscle Patch Constructs for Prevention of Post-infarction LV Remodeling